EZH2 genetic alterations in follicular and peripheral T-cell lymphoma and correlation with immunohistochemistry

Background: Mutations in Enhancer of zeste homolog 2 (EZH2) are common events in lymphoma pathogenesis.1 Recent studies have suggested that the presence of mutations in EZH2 may have prognostic2 and therapeutic implications.